Amneal Pharmaceuticals【AMRX】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

8.07

買値

8.07

売値

8.26

出来高

1,267,400

7.775 日の範囲 8.18

5.01 52 週間の範囲 9.475

時価総額

2.5B

前日終値

7.75

始値

7.78

時刻

8.0706

最終取引時間

財務取引量

US$ 10,237,254

VWAP

8.0774

平均取引量 (3 か月)

1,034,257

発行済株式数

309,844,430

配当利回り

PER

-21.65

1 株当たり利益 (EPS)

-0.27

歳入

2.41B

純利益

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.amneal.com

本社

Wilmington, Delaware, USA

設立

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker AMRX. The last closing price for Amneal Pharmaceuticals was US$7.75. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of US$ 5.01 to US$ 9.475.

Amneal Pharmaceuticals currently has 309,844,430 shares in issue. The market capitalisation of Amneal Pharmaceuticals is US$2.40 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.65.

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in developing GLP-1 injectables Amneal...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	8.07	8.33	7.68	803147	7.93993838	CS
4	-0.2	-2.41837968561	8.27	8.9	7.68	1067201	8.35347155	CS
12	-0.45	-5.28169014085	8.52	9.475	7.52	1034257	8.51937607	CS
26	1.22	17.8102189781	6.85	9.475	6.29	1252219	7.91645198	CS
52	2.19	37.2448979592	5.88	9.475	5.01	1372535	6.8894188	CS
156	2.19	37.2448979592	5.88	9.475	5.01	1372535	6.8894188	CS
260	2.19	37.2448979592	5.88	9.475	5.01	1372535	6.8894188	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
NUKKNukkleus Inc	US$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	US$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	US$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	US$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	US$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	US$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	US$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	US$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	US$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	US$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	US$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.335 (-36.79%)	1B
GOEVCanoo Inc	US$ 0.118 (7.08%)	382.65M
NVDANVIDIA Corporation	US$ 130.39 (-1.22%)	251.71M
XTIAXTI Aerospace Inc	US$ 0.0442 (8.33%)	221.41M